Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

James Allred

Clinical Cardiac Electrophysiology Greensboro, NC Medical Doctor

NPI 1669583316 CMS profile 210906

1126 N Church St Ste 300, Greensboro, NC 27401

Open in the dashboard

General payments

$183,579

466 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$1,671,270 paid to institutions, not to them · program years 2019–2024

Through program year 2025, James Allred of Greensboro, NC is reported in the CMS Open Payments database as having received $183,579 across 466 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $1,671,270 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 93rd percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,793 14
2024 General $1,523 11
2023 General $4,748 40
2022 General $38,630 120
2021 General $23,998 55
2020 General $36,209 72
2019 General $75,679 154

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • James Allred
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to James Allred were reported at $2,793. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year James Allred Clinical Cardiac Electrophysiology median Middle half National median
2019 $75,679 $2,361 $585–$8,260 $163
2020 $36,209 $993 $247–$4,351 $114
2021 $23,998 $1,185 $326–$4,739 $132
2022 $38,630 $2,073 $554–$6,789 $149
2023 $4,748 $2,568 $759–$8,159 $160
2024 $1,523 $2,557 $703–$7,403 $164
2025 $2,793 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Biosense Webster, Inc. $54,167 40 payments
  2. Medtronic Vascular, Inc. $36,348 101 payments
  3. Janssen Pharmaceuticals, Inc $28,190 51 payments
  4. Sanofi-Aventis U.S. LLC $22,312 13 payments
  5. CVRx, Inc. $13,405 25 payments
  6. Abbott Laboratories $12,209 90 payments
  7. Medtronic, Inc. $8,299 53 payments
  8. Medical Device Business Services, Inc. $5,209 5 payments
  9. AltaThera Pharmaceuticals LLC $1,500 1 payment
  10. Boston Scientific Corporation $459 9 payments
  11. Other $1,480 78 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $94,465 55 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $60,830 26 payments
  3. Travel and Lodging $15,117 30 payments
  4. Food and Beverage $11,667 354 payments
  5. Honoraria $1,500 1 payment
Products named General payments · program years 2019–2025
  1. Carto 3 System $32,013 18 payments
  2. XARELTO $28,190 51 payments
  3. Carto 3 $27,061 18 payments
  4. Barostim Neo System $13,405 25 payments
  5. Reveal LINQ $8,117 46 payments
  6. MULTAQ Cardiovascular $4,808 1 payment
  7. MULTAQ Cardiology/Vascular Diseases $4,555 3 payments
  8. DISEASE STATE $3,970 2 payments
  9. AVEIR $3,296 11 payments
  10. Carto Smarttouch $3,217 3 payments
  11. Other $16,714 258 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 11 drugs

Part D claims

299

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$155,508

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

56.9%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 81 $88,775
Xarelto Rivaroxaban Brand 54 $53,290
Repatha Sureclick Evolocumab Brand 18 $9,648
Dofetilide Generic 21 $2,419
Metoprolol Succinate Generic 35 $396
Diltiazem 24hr Er (Cd) Diltiazem Hcl Brand 17 $309
Losartan Potassium Generic 13 $183
Metoprolol Tartrate Generic 20 $154
Atorvastatin Calcium Generic 11 $146
Amiodarone Hcl Generic 15 $112

The 10 drugs with the highest cost, of 11 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 6 billing codes

Paid by Medicare

$922

Medicare's payments for the services billed

Medicare patients

15

Average age 76

Services billed

25

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Cancer 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
VYNDAQEL
  • PFIZER INC. $20
$20 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

466 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record